Serum free DNA and COX-2 mRNA expression in peripheral blood for lung cancer detection

Thorax

Volumn 63, Issue 9, 2008, Pages 843-844

  Ulivi, P ^a   Mercatali, L ^a   Zoli, W ^a   Dell'Amore, D ^b   Poletti, V ^b   Casoni, G L ^b   Scarpi, E ^a   Flamini, E ^a   Amadori, D ^a   Silvestrini, R ^a  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^b MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DNA; MESSENGER RNA;

ADULT; AREA UNDER THE CURVE; BLOOD; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LETTER; LOGISTIC REGRESSION ANALYSIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SMOKING HABIT; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STATISTICAL SIGNIFICANCE;

EID: 51249107541     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2008.102178     Document Type: Letter

References (7)

1. Mountain CF. The international system for staging lung cancer. Semin Surg Oncol 2000;18:106-15.
2. Jett JR. Limitations of screening for lung cancer with low-dose spiral computed tomography. Clin Cancer Res 2005;11:4988-92.
3. Sozzi G, Conte D, Leon ME, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003;21:3902-8.
4. Flamini E, Mercatali L, Nanni O, et al. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Clin Cancer Res 2006;12:2985-8.
5. Gal S, Fidler C, Lo YM, et al. Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR. Br J Cancer 2004;90:1211-5.
6. Mascaux C, Martin B, Vardebout JM, et al. COX-2 expression during early lung squamous cell carcinoma oncogenesis. Eur Respir J 2005;26:198-203.
7. Khuri FR, Wu H, Lee J, et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res 2001;7:861-7.